A Disintegrin and Metalloproteinase 10 Regulates Ephrin B2–Mediated Endothelial Cell Sprouting and Ischemic Retinopathy
- 17 April 2025
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 195 (7) , 1311-1327
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness
- National Eye Institute (EY029709, P30EY04068)
This publication has 61 references indexed in Scilit:
- The metalloproteinase ADAM10 requires its activity to sustain surface expressionCellular and Molecular Life Sciences, 2020
- Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 SignalingEBioMedicine, 2015
- Myeloid A Disintegrin and Metalloproteinase Domain 10 Deficiency Modulates Atherosclerotic Plaque Composition by Shifting the Balance from Inflammation toward FibrosisThe American Journal of Pathology, 2015
- ADAM10 and ADAM17 have opposite roles during sprouting angiogenesisAngiogenesis, 2014
- Adam10 is essential for early embryonic cardiovascular developmentDevelopmental Dynamics, 2010
- Retinopathy of prematurityAngiogenesis, 2007
- Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic RetinopathyArchives of Ophthalmology (1950), 2006
- Endothelial-pericyte interactions in angiogenesisCell and tissue research, 2003
- Expression of EphrinB2 Identifies a Stable Genetic Difference Between Arterial and Venous Vascular Smooth Muscle as Well as Endothelial Cells, and Marks Subsets of Microvessels at Sites of Adult NeovascularizationDevelopmental Biology, 2001
- Ephrin-B2 Selectively Marks Arterial Vessels and Neovascularization Sites in the Adult, with Expression in Both Endothelial and Smooth-Muscle CellsDevelopmental Biology, 2001